Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8758 |
High Similarity |
NPD3882 |
Suspended |
0.8457 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8405 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8293 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8284 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8284 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8137 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8137 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8137 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8133 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.811 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8086 |
Intermediate Similarity |
NPD1512 |
Approved |
0.805 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8047 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8036 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7976 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7955 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7886 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7875 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7853 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7829 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7829 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7803 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7778 |
Intermediate Similarity |
NPD919 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.774 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7705 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7673 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7658 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7658 |
Intermediate Similarity |
NPD943 |
Approved |
0.7654 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7593 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD37 |
Approved |
0.7582 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7558 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7543 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7543 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7531 |
Intermediate Similarity |
NPD2796 |
Approved |
0.75 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7455 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7358 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7349 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD9494 |
Approved |
0.733 |
Intermediate Similarity |
NPD6776 |
Approved |
0.733 |
Intermediate Similarity |
NPD6779 |
Approved |
0.733 |
Intermediate Similarity |
NPD6780 |
Approved |
0.733 |
Intermediate Similarity |
NPD6781 |
Approved |
0.733 |
Intermediate Similarity |
NPD6777 |
Approved |
0.733 |
Intermediate Similarity |
NPD6778 |
Approved |
0.733 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7327 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7326 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7317 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7314 |
Intermediate Similarity |
NPD3749 |
Approved |
0.731 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7306 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7297 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD920 |
Approved |
0.7284 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7247 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.724 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7228 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7219 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7202 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7191 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7167 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7128 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7118 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7113 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7113 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7108 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7102 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7092 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7092 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7085 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7085 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7077 |
Intermediate Similarity |
NPD3057 |
Approved |
0.7076 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7066 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7065 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7043 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7043 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7041 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7041 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7041 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7027 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7025 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7012 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7 |
Intermediate Similarity |
NPD2309 |
Approved |
0.6995 |
Remote Similarity |
NPD2973 |
Approved |
0.6995 |
Remote Similarity |
NPD2974 |
Approved |
0.6995 |
Remote Similarity |
NPD2975 |
Approved |
0.699 |
Remote Similarity |
NPD2972 |
Approved |
0.699 |
Remote Similarity |
NPD2491 |
Approved |
0.699 |
Remote Similarity |
NPD3533 |
Approved |
0.6982 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6965 |
Remote Similarity |
NPD7801 |
Approved |
0.6959 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD1653 |
Approved |
0.6949 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6949 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6935 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD5090 |
Approved |
0.6932 |
Remote Similarity |
NPD5089 |
Approved |
0.6919 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6919 |
Remote Similarity |
NPD8319 |
Approved |
0.6915 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6909 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6907 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6904 |
Remote Similarity |
NPD3448 |
Approved |
0.6898 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6888 |
Remote Similarity |
NPD4580 |
Approved |
0.6884 |
Remote Similarity |
NPD7048 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD2654 |
Approved |
0.6879 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD6355 |
Discontinued |
0.686
|
Remote Similarity |
NPD3300 |
Phase 2 |